MetaCap

Replimune Group Quarterly Cash Flow Statement

NASDAQ: REPLHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

19.07-0.16 (-0.83%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Replimune Group free cash flow

In the quarter ended Sep 30, 2026, Replimune Group generated -$47.7 million of operating cash flow and spent $77,000 on capital expenditures. That left free cash flow of -$47.8 million.

Summary generated from market data by MetaCap's automated system. Methodology

Replimune Group cash flow statement (quarterly)

Replimune Group quarterly cash flow statement
Quarter (USD)Q2 20272026-09-30Q1 20272026-06-30Q4 20262026-03-31Q3 20262025-12-31Q2 20262025-09-30Q1 20262025-06-30Q4 20252025-03-31Q3 20252024-12-31Q2 20252024-09-30Q1 20252024-06-30Q4 20242024-03-31Q3 20242023-12-31
Net Income-57.12M-69.77M-73.22M-70.93M-83.10M-86.69M-74.13M-66.34M-53.05M-53.77M-55.08M-51.12M
Net Income growth (YoY)————————————
Depreciation & Amortization800.00K937.00K769.00K800.00K800.00K873.00K848.00K1.00M900.00K736.00K705.00K700.00K
Stock-Based Compensation10.54M7.67M8.13M7.05M8.34M8.76M8.28M8.64M8.65M9.47M7.92M8.24M
Change in Working Capital788.00K795.00K594.00K-694.00K-9.07M4.00M4.89M-643.00K5.24M202.00K-856.00K-444.00K
Operating Cash Flow-47.70M-75.73M-56.16M-65.95M-81.21M-77.02M-53.73M-50.71M-38.64M-49.17M-46.17M-47.12M
Capital Expenditures-77.00K-6.00K-5.00K-135.00K-1.34M-2.74M-1.13M-1.80M-2.08M-1.67M-1.74M-1.72M
Investing Cash Flow9.76M49.99M86.51M75.12M84.17M65.05M-7.70M-46.32M458.00K29.77M23.20M53.96M
Debt Issued——————0———0—
Financing Cash Flow160.55M800.00K55.68M10.45M324.00K-158.00K-132.00K155.93M-39.00K96.64M-130.00K14.87M
Net Change in Cash122.47M-23.66M86.07M20.65M4.92M-13.74M-61.12M58.75M-38.16M77.20M-23.15M21.68M
Free Cash Flow-47.78M-75.73M-56.17M-66.09M-82.56M-79.76M-54.87M-52.51M-40.72M-50.84M-47.91M-48.84M

This table shows 12 quarterly periods of Replimune Group's cash flow statement, from Q2 2027 back to Q3 2024, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow REPL's reporting calendar. What is a cash flow statement?

More financial data